Unknown

Dataset Information

0

Design of PD-L1 inhibitors for lung cancer.


ABSTRACT: The progression of lung cancer is associated with inactivation of programmed cell death protein 1, abbreviated as PD- 1 which regulates the suppression of the body's immune system by suppressing T- cell inflammatory activity and is responsible for preventing cancer cell growth. It is of interest to identify inhibitors for PD-L1 dimeric structure through molecular docking and virtual screening. The virtual screened compound XGIQBUNWFCCMAS-UHFFFAOYSA-N (PubChem CID: 127263272) displays a high affinity with the target protein. ADMET analysis and cytotoxicity studies further add weight to this compound as a potential inhibitor of PD-L1. The established compound BMS-202 still shows the high re-rank score, but the virtual screened drug possesses a better ADMET profile with a higher intestinal absorption value and lower toxicity.

SUBMITTER: Udhwani T 

PROVIDER: S-EPMC6677907 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications


The progression of lung cancer is associated with inactivation of programmed cell death protein 1, abbreviated as PD- 1 which regulates the suppression of the body's immune system by suppressing T- cell inflammatory activity and is responsible for preventing cancer cell growth. It is of interest to identify inhibitors for PD-L1 dimeric structure through molecular docking and virtual screening. The virtual screened compound XGIQBUNWFCCMAS-UHFFFAOYSA-N (PubChem CID: 127263272) displays a high affi  ...[more]

Similar Datasets

| S-EPMC6580087 | biostudies-literature
| S-EPMC5784856 | biostudies-other
| S-EPMC6367228 | biostudies-literature
| S-EPMC5499002 | biostudies-literature
| S-EPMC5994502 | biostudies-literature
| S-EPMC5353357 | biostudies-literature
| S-EPMC5516873 | biostudies-literature
| S-EPMC8753312 | biostudies-literature
| S-EPMC7873939 | biostudies-literature
| S-EPMC4516625 | biostudies-literature